CCL2 and metabolic syndrome: Although reduced, healthy mice receiving statins still demonstrated induction of MCP-1, and CXCL1 following AgNP exposure (Figures 3C–E) while MetS mice receiving statins still exhibited induction of MIP-2, IL-6, MCP-1, and CXCL1 (Figures 3A,C,E).